| Videos | Channels | Search |
#SaxoStrats: Buying Gilead Sciences ahead of Q4... (01:45)Saxo Bank’s Head of Equity Strategy Peter Garnry is looking to buy...
|
Earnings Season: GSK will disappoint but pharma... (02:29)Expect them to be disappointing. That's what Saxo's Peter Garnry...
|
Are high returns from marijuana companies just... (05:18)This week the New York Times, in an editorial, urged US lawmakers...
|
Berger: Biogen's healthy recovery (02:06)Serge Berger suggests buying Biogen, a biotech firm which has...
|
Garnry: "Astra Zeneca shareholders blew it" (02:54)AstraZeneca’s stock price tumbled 14 percent on Monday morning...
|
Astra Zeneca and Pfizer: Five things you need... (00:58)As the Astra Zeneca Pfizer deal gets more bad tempered and...
|
Pfizer-AstraZeneca: 'Deal will likely get done' (01:28)What next in the drama surrounding the proposed merger of...
|
Switch to